157 related articles for article (PubMed ID: 29039571)
41. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
[TBL] [Abstract][Full Text] [Related]
43. LncRNA FTX activates FOXA2 expression to inhibit non-small-cell lung cancer proliferation and metastasis.
Jin S; He J; Zhou Y; Wu D; Li J; Gao W
J Cell Mol Med; 2020 Apr; 24(8):4839-4849. PubMed ID: 32176463
[TBL] [Abstract][Full Text] [Related]
44. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
[TBL] [Abstract][Full Text] [Related]
46. The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients.
Li X; Yu Z; Li Y; Liu S; Gao C; Hou X; Yao R; Cui L
Int J Oncol; 2015 Feb; 46(2):798-808. PubMed ID: 25531908
[TBL] [Abstract][Full Text] [Related]
47. miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
Wang P; Lv HY; Zhou DM; Zhang EN
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323056
[TBL] [Abstract][Full Text] [Related]
48. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.
Wang P; Deng Y; Fu X
Biochem Biophys Res Commun; 2017 Jan; 482(4):935-941. PubMed ID: 27894843
[TBL] [Abstract][Full Text] [Related]
49. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
50. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
Shi X; Zhan L; Xiao C; Lei Z; Yang H; Wang L; Zhao J; Zhang HT
Oncotarget; 2015 Aug; 6(22):19043-54. PubMed ID: 26189214
[TBL] [Abstract][Full Text] [Related]
51. Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis.
Desi N; Tong QY; Teh V; Chan JJ; Zhang B; Tabatabaeian H; Tan HQ; Kapeli K; Jin W; Lim CY; Kwok ZH; Tan HT; Wang S; Siew BE; Lee KC; Chong CS; Tan KK; Yang H; Kappei D; Yeo GW; Chung MCM; Tay Y
Cell Mol Life Sci; 2022 Feb; 79(3):147. PubMed ID: 35195778
[TBL] [Abstract][Full Text] [Related]
52. Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer.
Gu A; Lu J; Wang W; Shi C; Han B; Yao M
Int J Biochem Cell Biol; 2016 Jan; 70():118-25. PubMed ID: 26485685
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells.
Shi H; Ji Y; Zhang D; Liu Y; Fang P
Oncol Rep; 2016 Nov; 36(5):3051-3057. PubMed ID: 27599551
[TBL] [Abstract][Full Text] [Related]
54. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
55. Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.
Bao X; Ren T; Huang Y; Sun K; Wang S; Liu K; Zheng B; Guo W
Cell Death Dis; 2017 Feb; 8(2):e2605. PubMed ID: 28182000
[TBL] [Abstract][Full Text] [Related]
56. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
[TBL] [Abstract][Full Text] [Related]
57. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
58. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
Zhu X; Li D; Yu F; Jia C; Xie J; Ma Y; Fan S; Cai H; Luo Q; Lv Z; Fan L
Oncotarget; 2016 Mar; 7(11):13139-52. PubMed ID: 26909612
[TBL] [Abstract][Full Text] [Related]
59. RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis.
Wu D; Nie X; Ma C; Liu X; Liang X; An Y; Zhao B; Wu X
Biomed Pharmacother; 2017 Nov; 95():207-214. PubMed ID: 28843909
[TBL] [Abstract][Full Text] [Related]
60. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.
Zhu K; Ding H; Wang W; Liao Z; Fu Z; Hong Y; Zhou Y; Zhang CY; Chen X
Oncotarget; 2016 May; 7(19):28075-85. PubMed ID: 27057632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]